ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

Molecular Neurodegeneration

Volumn 9, Issue 1, 2014, Pages

  Medway, Christopher W ^a   Abdul Hay, Samer ^a   Mims, Tynickwa ^a   Ma, Li ^a   Bisceglio, Gina ^a   Zou, Fanggeng ^a   Pankratz, Shane ^b   Sando, Sigrid B ^c,d   Aasly, Jan O ^c,d   Barcikowska, Maria ^e   Siuda, Joanna ^a,f   Wszolek, Zbigniew K ^a   Ross, Owen A ^a   Carrasquillo, Minerva ^a   Dickson, Dennis W ^a   Graff Radford, Neill ^a   Petersen, Ronald C ^b,g   Ertekin Taner, Nilüfer ^a   Morgan, Kevin ^h   Bu, Guojun ^a   Younkin, Steven G ^a   more..

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; ARGININE; CYSTEINE; GLUTAMIC ACID; LIPID BINDING PROTEIN; LYSINE; PROLINE; VALINE;

ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FOLLOW UP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTICENTER STUDY; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899116901     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-9-11     Document Type: Article

References (18)

1. The international HapMap project. Tanaka T, Nature 2003 426 789 796 10.1038/nature02168 14685227
2. Role of genes and environments for explaining Alzheimer disease. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL, Arch Gen Psychiatry 2006 63 168 174 10.1001/archpsyc.63.2.168 16461860
3. Variant of TREM2 associated with the risk of Alzheimer's disease. Jonsson T, Stefansson H, Ph.D SS, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen O a, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K, N Engl J Med 2013 368 107 116 10.1056/NEJMoa1211103 23150908
4. TREM2 Variants in Alzheimer's disease. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JSK, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert J-C, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St. George-Hyslop P, Singleton A, Hardy J, N Engl J Med 2013 368 117 127 10.1056/NEJMoa1211851 23150934
5. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Kamboh MI, Aston CE, Perez-Tur J, Kokmen E, Ferrell RE, Hardy J, DeKosky ST, Neurosci Lett 1999 263 129 132 10.1016/S0304-3940(99)00129-9 10213152
6. Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population. Baron M, Jimenez-Escrig A, Orensanz L, Simon J, Perez-Tur J, Am J Med Genet B Neuropsychiatr Genet 2003 120B 121 124 10.1002/ajmg.b.20028 12815750
7. Screening of two mutations at exon 3 of the apolipoprotein E gene (sites 28 and 42) in a sample of patients with sporadic late-onset Alzheimer's disease. Scacchi R, Gambina G, Ferrari G, Corbo RM, Neurobiol Aging 2003 24 339 343 10.1016/S0197-4580(02)00089-1 12498968
8. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Chen J, Li Q, Wang J, Proc Natl Acad Sci USA 2011 108 14813 14818 10.1073/pnas.1106420108 21873229
9. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Bu G, Nat Rev Neurosci 2009 10 333 344 10.1038/nrn2620 19339974
10. Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. van den Maagdenberg a M, Weng W, de Bruijn IH, de Knijff P, Funke H, Smelt a H, Gevers Leuven J a, van't Hooft FM, Assmann G, Hofker MH, Am J Hum Genet 1993 52 937 946 8488843
11. Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia. Zhao SP, van den Maagdenberg AM, Vroom TF, van 't Hooft FM, Gevers Leuvens JA, Havekes LM, Frants RR, Van der Laarse A, Smelt AH, Clin Sci (Lond) 1994 86 323 329 8156744
12. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease. Frieden C, Garai K, Proc Natl Acad Sci USA 2012 109 8913 8918 10.1073/pnas.1207022109 22615372
13. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO, BMC Neurol 2008 8 9 10.1186/1471-2377-8-9 18416843
14. The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk. Maruszak A, Safranow K, Branicki W, Gawȩda-Walerych K, Pośpiech E, Gabryelewicz T, Canter JA, Barcikowska M, Zekanowski C, J Alzheimers Dis 2011 27 197 210 21799244
15. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. Klimkowicz-Mrowiec A, Marona M, Wołkow P, Maruszak A, Styczynska M, Barcikowska M, Zekanowski C, Szczudlik A, Slowik A, Dement Geriatr Cogn Disord 2009 28 461 464 10.1159/000259460 19940477
16. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 939 944 10.1212/WNL.34.7.939 6610841
17. Exome variant server, NHLBI GO exome sequencing project (ESP), Seattle, WA. [URL: http:///evs.gs.washington.edu/EVS (October 2013)]
18. PLINK: a tool set for whole-genome association and population-based linkage analyses. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC, Am J Hum Genet 2007 81 559 575 10.1086/519795 17701901